Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-10-28FDA Approved: VIMPAT — Original Application (UCB, Inc.)
FDA approved VIMPAT (lacosamide) under Original Application by UCB, Inc., marking the initial approval for the treatment of partial-onset se…
-
FDA approval · 2008-10-28FDA Approved: VIMPAT — Original Application (UCB, Inc.)
FDA approved VIMPAT (lacosamide) through its original NDA for adjunctive treatment of partial-onset seizures in adults and in pediatric pati…
-
FDA approval · 2008-09-12FDA Approved: KEPPRA XR — Original Application (UCB, Inc.)
The FDA approved KEPPRA XR (levetiracetam) under an original NDA from UCB, Inc., introducing an extended-release formulation of Keppra for e…
-
CLINICAL_TRIALS trial_result · 2008-09-12Clinical Trial Update: Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellectual Disability [NA]
This clinical trial compared immediate versus gradual switching to divalproex in adults with intellectual disability and epilepsy and has co…
-
FDA approval · 2008-09-10FDA Approved: LORAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for lorazepam submitted by Teva Pharmaceuticals USA, Inc., under the existing approval of the dr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-07-29FDA Approved: DIVALPROEX SODIUM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic divalproex sodium (Original Application), enabling a generic version of the reference product.
-
FDA approval · 2008-07-29FDA Approved: DIVALPROEX SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' divalproex sodium as an original ANDA (generic) application.
-
FDA approval · 2008-07-29FDA Approved: DIVALPROEX SODIUM — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved a generic version of divalproex sodium from Dr. Reddy's Laboratories Limited under an Original Application (ANDA).
-
FDA approval · 2008-07-28FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for carbamazepine (generic), signifying approval of a supplemental ANDA for this produc…
-
FDA approval · 2008-07-23FDA Approved: DIAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for diazepam filed by Teva Pharmaceuticals USA, Inc., updating/expanding its labeling.
-
FDA approval · 2008-06-30FDA Approved: PHENYTOIN SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's Phenytoin Sodium as an oral generic anticonvulsant indicated for the control of seizures in epilepsy.
-
FDA approval · 2008-06-13FDA Approved: MYSOLINE — Supplemental Application (Bausch Health US, LLC)
FDA approves a supplemental application for Mysoline (primidone) submitted by Bausch Health US, LLC. The action approves changes to the prod…
-
CLINICAL_TRIALS trial_result · 2008-06-09Clinical Trial Update: Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
This clinical trial investigates whether SV2A expression in glioma tissue correlates with the efficacy of levetiracetam in patients with epi…
-
CLINICAL_TRIALS research · 2008-06-04Clinical Trial Update: PEARL Intervention to Reduce Depression Among Adults With Epilepsy [NA]
This ClinicalTrials.gov entry reports on the PEARL intervention to reduce depression in adults with epilepsy; the study status is unknown an…
-
CLINICAL_TRIALS trial_result · 2008-05-30Clinical Trial Update: Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis [Phase 3]
Phase 3 clinical trial comparing levetiracetam to carbamazepine for post-stroke late-onset seizures; status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation
An open-label study of zonisamide for epilepsy in patients with intellectual disability has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-05Clinical Trial Update: Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population [Phase 4]
Phase 4 pediatric epilepsy trial evaluating Depakote ER in children with intellectual disability and developmental disabilities has complete…
-
CLINICAL_TRIALS trial_result · 2008-04-24Clinical Trial Update: A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures [Phase 3]
A Phase 3 study evaluating pregabalin (Lyrica) for sleep problems in patients with sleep disorders and epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-24Clinical Trial Update: Lamotrigine and Oral Contraceptives [Phase 3]
A Phase 3 clinical trial evaluating lamotrigine in combination with oral contraceptives for epilepsy has been terminated.
-
FDA approval · 2008-04-23FDA Approved: PRIMIDONE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' original ANDA for Primidone, enabling the marketing of a generic Primidone product.
-
FDA approval · 2008-04-21FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine from Sun Pharmaceutical Industries, Inc., updating the approved generic product un…
-
FDA approval · 2008-04-17FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2008-04-09FDA Approved: OXCARBAZEPINE — Original Application (Advagen Pharma Limited)
The FDA approved Advagen Pharma Limited's original ANDA for oxcarbazepine, a generic anticonvulsant.
-
CLINICAL_TRIALS trial_result · 2008-04-04Clinical Trial Update: Bioavailability Study of Clonazepam ODT Under Fasting Conditions [Phase 1]
This document notes the completion of a Phase 1 bioavailability study of clonazepam orally disintegrating tablets under fasting conditions t…
-
CLINICAL_TRIALS trial_result · 2008-03-31Clinical Trial Update: The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy [Phase 4]
Phase 4 clinical trial update examining whether reducing overtreatment improves quality of life in children with refractory epilepsy.